Sign in

CIK 0001800315

  • Non-accelerated filer
  • Smaller reporting company

Damora Therapeutics, Inc.

Sign in to watch
Ticker
DMRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
371957007
Phone
+1 781-281-9020
Business address
100 FIFTH AVENUE, SUITE 700, WALTHAM, MA, 02451
Former names
Galecto, Inc., Galecto Inc.
Open-market buys, last 90 days
$252,875
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$252,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Jarrett Jennifer +$253K Director, President and CEO 1 filing
Date Insider Transaction Shares Price Value Owned after
2026-09-25 Jarrett Jennifer Director, President and CEO Purchase +12,500 $20.23 $253K 512,500
2026-08-12 Cheng Andrew Director Grant or award · Stock Option (right to buy) +30,350 30,350
2026-07-06 Winslow Garrett General Counsel Sale −245 $29.98 $7K 2,289
2026-07-03 Winslow Garrett General Counsel Option exercise +680 2,534
2026-07-03 Winslow Garrett General Counsel Option exercise · Restricted Stock Units −680 640
2026-03-30 Jarrett Jennifer See Remarks Grant or award +500,000 500,000
2026-03-30 Jarrett Jennifer See Remarks Grant or award · Stock Option (right to buy) +1,500,000 1,500,000
2026-03-23 Winslow Garrett General Counsel Grant or award · Stock Option (right to buy) +250,000 250,000
2026-03-23 Turtle Cameron Director Grant or award · Stock Option (right to buy) +37,313 37,313
2026-03-23 Landsittel Michael Director Grant or award · Stock Option (right to buy) +37,313 37,313
2026-03-23 Fairmount Funds Management LLC Director Grant or award · Stock Option (right to buy) +37,313 37,313
2026-03-23 CAIN CHRISTOPHER W. Director Grant or award · Stock Option (right to buy) +37,313 37,313
2026-03-23 Bruno Julianne Director Grant or award · Stock Option (right to buy) +37,313 37,313
2026-02-09 Bruno Julianne Director Option exercise +129,000 137,032
2026-02-09 Bruno Julianne Director Option exercise · Series C Preferred Stock −129 0
2026-02-09 Fairmount Funds Management LLC Director Option exercise +5,809,000 5,809,000
2026-02-09 Fairmount Funds Management LLC Director Option exercise +2,904,000 2,904,000
2026-02-09 Fairmount Funds Management LLC Director Option exercise · Series C Preferred Stock −5,809 1,148
2026-02-09 Fairmount Funds Management LLC Director Option exercise · Series C Preferred Stock −2,904 574
2026-01-05 Sattarzadeh Sherwin Chief Operating Officer Grant or award +190,376 190,376

Page 1 of 12 · 227 trades